semaglutide for hfpef Efficacy and safety of in patients with heart failure with preserved ejection fraction and obesity - Rehman - 2024 - Clinical Cardiology STEP-HFpEF Trial

This metabolic adaptation can slow your weekly weight loss from 23 pounds to less than 1 pound per week, making further progress feel stalled even though your body is still changing

It's one of the first questions patients ask their providers, and honestly, it's the right question to ask

However, individuals with a history of anorexia deserve thoughtful screening, informed decision making, and careful monitoring

Mounjaro (tirzepatide) targets GLP-1 and GIP receptors, giving it a dual effect

Regular followup and adjustments are essential, and providers should set realistic expectations with patients from the outset

Edden, R